TNYA today
$0.35-$0.02 (-6.38%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bearish
1 hourStrong Bearish
15 minStrong Bearish
5 minStrong Bearish
Daily trend turns up above $0.59
Key levels
Resistance$0.41
Resistance$0.36
Support$0.30
Latest news & SEC filings
EarningsTenaya Therapeutics Posts Q3 2026 Results, Business Update
EarningsTenaya Therapeutics posts smaller Q3 loss than expected, revenue tops forecast
All TNYA news →About Tenaya Therapeutics
Tenaya Therapeutics is a clinical-stage biotechnology company focused on treatments for heart disease. Its most advanced candidates are gene therapies for inherited heart muscle conditions, one targeting a common genetic form of hypertrophic cardiomyopathy and another aimed at an inherited arrhythmia disorder. The company also has a small molecule drug candidate for heart failure and related cardiac, muscle and metabolic diseases, along with earlier-stage programs and a research partnership with Alnylam on cardiovascular gene targets.
Based on the company's 10-K filed Mar 11, 2026.
Nasdaq · Healthcare
Tenaya Therapeutics, Inc. (TNYA)
What Is the Price Target for TNYA?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is TNYA a Buy or Sell Right Now?
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for TNYA.
Start Free Trial →Is TNYA Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B
Fair Value
$0.83
12
Moat Score
NONE
4/9
Piotroski Score
-5.7
Altman Z-Score
What Is Smart Money Doing with TNYA?
Insider Signal
SELLING
0 buys / 18 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Ali Faraz | director officer | Buy | 122,000 | - | Sep 10, 2026 |
| Tingley Whittemore | officer | Buy | 49,000 | - | Sep 10, 2026 |
| Ali Faraz | director officer | Sale | 3,390 | $3K | May 18, 2026 |
| Tingley Whittemore | officer | Sale | 3,121 | $2K | May 18, 2026 |
| Higa Tomohiro | officer | Sale | 1,485 | $1K | May 18, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →TNYA Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
54.96%
FCF Growth YoY
24.7%
Revenue Trend
UNKNOWN
Dark Pool Trades for TNYA
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for TNYA, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 24:23:10 | $0.34 | 2,900 | $$998 | SELL |
| 24:18:58 | $0.35 | 1,512 | $$526 | SELL |
| 24:07:59 | $0.35 | 2,000 | $$701 | SELL |
| 24:03:20 | $0.35 | 2,001 | $$701 | SELL |
| 24:00:04 | $0.35 | 1,000 | $$350 | SELL |
5 dark pool trades shown · $$3K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Tenaya Therapeutics, Inc. (TNYA) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →TNYA — frequently asked questions
What is TNYA stock price today?
Tenaya Therapeutics, Inc. (TNYA) is at $0.35, down 6.38% (-$0.02) at the Nov 12, 2026 close.
Why is TNYA stock moving today?
Latest TNYA news — Nov 5, 2026: Tenaya Therapeutics Posts Q3 2026 Results, Business Update · Nov 4, 2026: Tenaya Therapeutics posts smaller Q3 loss than expected, revenue tops forecast
What do analysts rate TNYA?
Analyst ratings for TNYA: 6 Buy, 0 Hold, 0 Sell — consensus Strong Buy.
Did TNYA beat earnings?
TNYA last reported on Nov 4, 2026: EPS -$0.08 vs -$0.10 expected — a beat of 20.0%.
Does TNYA pay a dividend?
TNYA does not currently pay a dividend.
What are TNYA support and resistance levels?
Support: $0.30. Resistance: $0.36, $0.41, $0.51.
What are insiders doing with TNYA?
Insider activity: SELLING, 0 buys and 18 sells in the last 90 days.
What is the latest news on TNYA?
Nov 5, 2026: Tenaya Therapeutics Posts Q3 2026 Results, Business Update · Nov 4, 2026: Tenaya Therapeutics posts smaller Q3 loss than expected, revenue tops forecast